The prognostic value of KRAS and BRAF in stage I-III colorectal cancer. A systematic review.
CONCLUSION: In our opinion, a combination of molecular markers, tumor location with the other clinical-pathological variables and microsatellite status is essential to have a correct prognosis. Nevertheless, this combination could be useful as a predictive factor in stage I-III CRC.
KEY WORDS: BRAF, Colorectal Cancer, KRAS, Stage I-III CRC, Translational research.
PMID: 30739887 [PubMed - as supplied by publisher]
Source: Annali Italiani di Chirurgia - Category: Surgery Tags: Ann Ital Chir Source Type: research
More News: Cancer | Cancer & Oncology | Chemotherapy | Colorectal Cancer | Databases & Libraries | Environmental Health | Gastroschisis Repair | Genetics | Science | Study | Surgery